HCA Q2 Profit Rises to $1.7B, Revenue Hits $20.2B; Full-Year Revenue Guidance Set at $77B-$79.5B
HCA is trading near its 52-week low of $330 (12% above the low).
Summary
HCA Healthcare reported Q2 GAAP EPS of $7.62, up from $6.83 a year ago, on revenue of $20.23 billion, an 8.7% increase. Adjusted EPS came in at $7.59. The results confirm the strong top-line pre-announced on July 14, but add bottom-line details and new full-year revenue guidance of $77.0 billion to $79.5 billion. The profit was boosted by a Florida Medicaid program. This follows the July 14 guidance cut for EPS and the July 24 EBITDA guidance release, providing a more complete picture of profitability. The revenue beat and raised full-year revenue outlook suggest demand remains robust despite cost pressures from uncompensated care.
At the time of this announcement, HCA was trading at $369.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $83.5B. The 52-week trading range was $330.00 to $556.52. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.